US2364579A - Hog cholera vaccine - Google Patents

Hog cholera vaccine Download PDF

Info

Publication number
US2364579A
US2364579A US418839A US41883941A US2364579A US 2364579 A US2364579 A US 2364579A US 418839 A US418839 A US 418839A US 41883941 A US41883941 A US 41883941A US 2364579 A US2364579 A US 2364579A
Authority
US
United States
Prior art keywords
virus
vaccine
hog cholera
hog
serum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US418839A
Inventor
Ralph W G Wyckoff
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lederle Laboratories Inc
Original Assignee
Lederle Laboratories Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lederle Laboratories Inc filed Critical Lederle Laboratories Inc
Priority to US418839A priority Critical patent/US2364579A/en
Application granted granted Critical
Publication of US2364579A publication Critical patent/US2364579A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/187Hog cholera virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525Virus
    • A61K2039/5252Virus inactivated (killed)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505Inorganic adjuvants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/24011Flaviviridae
    • C12N2770/24311Pestivirus, e.g. bovine viral diarrhea virus
    • C12N2770/24334Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Definitions

  • This invention relates to the production of a hog cholera virus vaccine and is more particu-' larly concerned with such a vaccine associated with a finely divided adsorbing agent.
  • An illustrative vaccine is made by the followin A highly infectious spleen of a hog fully diseased with hog cholera is taken with suitable steril precautions. finely ground in a colloid mill or by some other suitable device and made to a 5% tissue suspension with sterile distilled water. After standing for several hours in a refrigerator, this spleen suspension is cleared of gross particles by low-speed centrifugation or in some other suitable fashion. Enough freshly drawn, highly infectious virus blood is then added to make the suspension 10% with respect to this blood. To.
  • the fluid thus obtained a 10% potash alum solution is slowly added with constant shaking until the pH of the final mixture has reached a value of 5.2, as determined by measurement with a glass electrode or other pH measuring device of suiiicient accuracy.
  • a brown precipitate is formed in the liquid shortly after addition of the potash alum solution starts and continues as long as this addition proceeds.
  • the suspension is allowed to stand for at least a day in the refrigerator beforefurther use. A better vaccine will result if the mixture is shaken continuously duringthe first 24 hours.
  • v During the manufacture of the vaccine enough phenol is added to make it 0.5% with respect to this chemical. After one or more clays ageing, and after appropriate tests to insure bacterial sterility, the vaccine is ready to use.
  • This adsorbed-virus vaccine could be made in a Other virus-containing number of other ways. organs of the hog, such as the liver, lymph nodes, blood, lungs, etc., could be used. Grinding could be carried out in different ways to provid a finer or a coarser suspension. Different proportions of tissue extract and of virus blood could be employed. Another adsorbent than hydrous aluminum oxide could be added or formed in the solution. The suspension could be made up with physiological salt solution or with buffered salt solution in place of distilled water.
  • the hydrous oxide precipitate could be made using aluminum salts other than potash alum.
  • alum solution was added to the amount-of approximately 0.2% in th virus suspension; satisfactory vaccine could be made with other amounts of alum especially if appropriate amounts of acid or alkali were added to give a final pH of 5.2.
  • other adsorbents than hydrousaluminum oxide could be formed in the virus solution or introduced into it for the production of satisfactory vaccine.
  • Suitabl adsorbents include calcium phosphate, silica gel, adsorbent'carbon, kieselguhr and similar materials which have no deleteriou effect when injected withthe vaccine.
  • the ratio of adsorbed virus to free virus is not especially critical It is a very important advantage of a vaccine compounded as outlined above that it is much more stable on storage than is the usual virus blood vaccine and that in consequence it has a much lengthened useful life.
  • McBryde and his coworkers of the United States Bureau of Animal Industry demonstrated that the optimum stability of the virus of hog cholera occurred not at the neutral pH of the blood but in an acid medium of pH 5.2. In reporting this work, these authors pointed out the advantages that would accrue from keeping and using virus at this acid pH, but they concluded that it was not practical since their blood vaccine gelled and solidified on being acidified.
  • a typical use of adsorbed-virus vaccine for the active immunization of hogs is the following: 60 pound, susceptible hogs are injected subcutaneously with 2 cc. of my partially adsorbed-virus vaccine. At the same time 14 cc. of hyperimmune hog serum is injected subcutaneously into the hog at another point. During the next two weeks vaccinated pigs may be expected to acquire an active immunity to hog cholera without exhibiting any fever or other clinical manifestations of the disease. This immunity may be demonstrated three weeks or more after injection by the subcutaneous injection of 1 cc. of highly virulent hog cholera. virus.
  • a hog cholera vaccine comprising hog cholera virus associated with hydrous aluminum oxide and an aqueous fluid in such an amount that part of the hog cholera virus is adsorbed onto the aluminum hydroxide, the rest being free in the liquid.
  • a hog cholera vaccine comprising hog cholera virus associated with hydrous aluminum oxide and an aqueous fluid in such an amount that part of the virus is adsorbed onto the aluminum hydroxide, the rest being free in the fluid and the entire mixture being at a pH of approximately 5.2.
  • the resulting suspension contains part of the virus adsorbed to the precipitated aluminum hydroxide and the rest of the virus is free in the aqueous fluid.
  • a process of preparing a hog cholera vaccine which comprises forming an aqueous suspension of infectious hog cholera virus, adding to the suspension an aqueous solution of potash alum until the mixture has a pH of about 5.2 whereby colloidal aluminum hydroxide is precipitated, the amount of aluminum hydroxide being such as to adsorb most but not all of the-virus.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Description

. procedure.
Armed Dec. 5, 1944 Boo CHOLERA VACCINE Ralph W. G. Wyckofl, Suflern, N. Y., assignor to Lederle Laboratories, Inc., New York, N. Y., a corporation of Delaware No Drawing. Application November 12, 1941, Serial No. 418,839
. 4 Claims. (Cl. 167-80) This invention relates to the production of a hog cholera virus vaccine and is more particu-' larly concerned with such a vaccine associated with a finely divided adsorbing agent.
This application is in part a continuation of my prior application Serial No. 332,503 filed April 30, 1940.
In the standard mode of vaccination of hogs against hog cholera, hyperimmune serum and virus are administered at the same time, there thus being produced a low-grade and controlled infection which gives rise to a powerful and lastin immunity. For successful vaccination by this methodgappropriate amounts of serum and virus must be administered; if too much virus in relation to serum is given; disease may result; if too little, adequate protection will not develop. In practical use it is difficult to be assured of a proper balance between these two agents because the virus vaccine now employed progressively loses potency. on standing. At present one seeks to circumvent this difficulty by giving the virus vaccine a short dating, but this procedure is at best only partially satisfactory and it is at the same time wasteful and costly.
It is one of the objects of the present invention to produce a cheaper, more stable and more effective virus vaccine for the active immunization of hogs against hog cholera. It is a further object to put the vaccine in such a form (1) that a less critical balance against serum will result, (2) that the minimal amount of serum will be required to counterbalance the virus necessary for successful vaccination, and (3) that the highest possible degree of immunity will be established through vaccination by the gradual, and pro' longed liberation of virus Within the body of the hog being immunized.
These and other objects are obtained by a vaccine containing aluminum hydroxide or other suitable finely divided adsorbing agent, preferably colloidal, in such an amount that part, but
. not all, of the virus from infected tissue or blood is adsorbed thereon. When such a partiallyadsorbed virus vaccin is injected into a susceptible hog, the free virus it contains is immediately available to initiate the immunizing process while the gradual liberation of that part .of
the infectious principle which is adsorbed insures a continued low-grade infection resulting in a high degree of resultant immunity.
An illustrative vaccine is made by the followin A highly infectious spleen of a hog fully diseased with hog cholera is taken with suitable steril precautions. finely ground in a colloid mill or by some other suitable device and made to a 5% tissue suspension with sterile distilled water. After standing for several hours in a refrigerator, this spleen suspension is cleared of gross particles by low-speed centrifugation or in some other suitable fashion. Enough freshly drawn, highly infectious virus blood is then added to make the suspension 10% with respect to this blood. To. the fluid thus obtained a 10% potash alum solution is slowly added with constant shaking until the pH of the final mixture has reached a value of 5.2, as determined by measurement with a glass electrode or other pH measuring device of suiiicient accuracy.- A brown precipitate ,begins to form in the liquid shortly after addition of the potash alum solution starts and continues as long as this addition proceeds. After the proper pH has been reached, the suspension is allowed to stand for at least a day in the refrigerator beforefurther use. A better vaccine will result if the mixture is shaken continuously duringthe first 24 hours. v During the manufacture of the vaccine enough phenol is added to make it 0.5% with respect to this chemical. After one or more clays ageing, and after appropriate tests to insure bacterial sterility, the vaccine is ready to use.
\ This adsorbed-virus vaccine could be made in a Other virus-containing number of other ways. organs of the hog, such as the liver, lymph nodes, blood, lungs, etc., could be used. Grinding could be carried out in different ways to provid a finer or a coarser suspension. Different proportions of tissue extract and of virus blood could be employed. Another adsorbent than hydrous aluminum oxide could be added or formed in the solution. The suspension could be made up with physiological salt solution or with buffered salt solution in place of distilled water.
The hydrous oxide precipitate could be made using aluminum salts other than potash alum.
In the typical example cited above, alum solutionwas added to the amount-of approximately 0.2% in th virus suspension; satisfactory vaccine could be made with other amounts of alum especially if appropriate amounts of acid or alkali were added to give a final pH of 5.2. As stated above, other adsorbents than hydrousaluminum oxide could be formed in the virus solution or introduced into it for the production of satisfactory vaccine. Suitabl adsorbents include calcium phosphate, silica gel, adsorbent'carbon, kieselguhr and similar materials which have no deleteriou effect when injected withthe vaccine. The ratio of adsorbed virus to free virus is not especially critical It is a very important advantage of a vaccine compounded as outlined above that it is much more stable on storage than is the usual virus blood vaccine and that in consequence it has a much lengthened useful life. In a work published several years ago, McBryde and his coworkers of the United States Bureau of Animal Industry demonstrated that the optimum stability of the virus of hog cholera occurred not at the neutral pH of the blood but in an acid medium of pH 5.2. In reporting this work, these authors pointed out the advantages that would accrue from keeping and using virus at this acid pH, but they concluded that it was not practical since their blood vaccine gelled and solidified on being acidified. The preparation of my partially adsorbed-virus vaccine at a 'pH of about 5.2 for the first time makes it possible to take advantage of the greatly enhanced stability of hog cholera virus at its point of maximum stability, since at this pH adsorption of the virus occurs under optimal conditions.
It is a further advantage of my partially adsorbed-virus vaccine that less than the usually recommended amount of serum need be used with it for the entirely safe and highly effective immunization of pigs. Safe vaccination can be obtainedwith a minimal dose of serum using my vaccine since the virus which is immediately liberated and must be counteracted by the added serum constitutes only a fraction of the total that is present in the injected vaccine.
A typical use of adsorbed-virus vaccine for the active immunization of hogs is the following: 60 pound, susceptible hogs are injected subcutaneously with 2 cc. of my partially adsorbed-virus vaccine. At the same time 14 cc. of hyperimmune hog serum is injected subcutaneously into the hog at another point. During the next two weeks vaccinated pigs may be expected to acquire an active immunity to hog cholera without exhibiting any fever or other clinical manifestations of the disease. This immunity may be demonstrated three weeks or more after injection by the subcutaneous injection of 1 cc. of highly virulent hog cholera. virus. It will be found that the immunity is sufficiently great so that no symptoms of hog cholera result from the administration of this test dose of virus. Two vaccinated control hogs receiving such a test dose ofvirus will develop fever and other symptoms of hog cholera in from 5 to 8 days after injection and will usually succumb to the disease within two weeks.
At the present time more than 1000 hogs have been immunized successfully with my vaccine using the scheme outlined above. In vaccinating these animals there have been no untoward reactions and no cases. of hog cholera have developed in a vaccinated animal either during the vaccination or at the subsequent time. Some of .cination with partially adsorbed-virus vaccine.
Successful vaccination would, however, result from the administration of a larger amount of serum and smaller amounts also could be used.
If very small volumes of serum are employed,
many pigs will be successfully vaccinated but a certain percentage may exhibit more or less severe symptoms of an active hog cholera infection. On
account of the gradual liberation of the infectious principle from my adsorbed-virus vaccine, a wider latitude is permissible in the amount of serum to be administered for safe and solid in!- munization.
For the purposes of sterilizing the vaccine, I may use other proportions of phenol than that specifically described. Likewise, any other antiseptic may be employed for all, or a part, of the phenol.
It will be obvious that other changes and variations may be made in preparing my vaccine and the invention is not restricted to the specific details described except as set forth in the claims.
I claim:
1. A hog cholera vaccine comprising hog cholera virus associated with hydrous aluminum oxide and an aqueous fluid in such an amount that part of the hog cholera virus is adsorbed onto the aluminum hydroxide, the rest being free in the liquid.
2. A hog cholera vaccine comprising hog cholera virus associated with hydrous aluminum oxide and an aqueous fluid in such an amount that part of the virus is adsorbed onto the aluminum hydroxide, the rest being free in the fluid and the entire mixture being at a pH of approximately 5.2.
ide in an amount such that the resulting suspension contains part of the virus adsorbed to the precipitated aluminum hydroxide and the rest of the virus is free in the aqueous fluid.
4. A process of preparing a hog cholera vaccine which comprises forming an aqueous suspension of infectious hog cholera virus, adding to the suspension an aqueous solution of potash alum until the mixture has a pH of about 5.2 whereby colloidal aluminum hydroxide is precipitated, the amount of aluminum hydroxide being such as to adsorb most but not all of the-virus.
RALPH W. G. WYCKOFF.
US418839A 1941-11-12 1941-11-12 Hog cholera vaccine Expired - Lifetime US2364579A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US418839A US2364579A (en) 1941-11-12 1941-11-12 Hog cholera vaccine

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US418839A US2364579A (en) 1941-11-12 1941-11-12 Hog cholera vaccine

Publications (1)

Publication Number Publication Date
US2364579A true US2364579A (en) 1944-12-05

Family

ID=23659750

Family Applications (1)

Application Number Title Priority Date Filing Date
US418839A Expired - Lifetime US2364579A (en) 1941-11-12 1941-11-12 Hog cholera vaccine

Country Status (1)

Country Link
US (1) US2364579A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3925545A (en) * 1972-04-06 1975-12-09 Pasteur Institut Process for preparing adsorbed vaccines
US4551431A (en) * 1983-04-21 1985-11-05 Phillips Petroleum Company The use of gallium and indium salts for the immobilization of proteins

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3925545A (en) * 1972-04-06 1975-12-09 Pasteur Institut Process for preparing adsorbed vaccines
US4551431A (en) * 1983-04-21 1985-11-05 Phillips Petroleum Company The use of gallium and indium salts for the immobilization of proteins

Similar Documents

Publication Publication Date Title
BRPI0007891B1 (en) process for producing il-1ra in a syringe for use as a medicine
US3456053A (en) Inactivated hog cholera virus vaccine
US2491537A (en) Liquid injectable oil-pectin-drug therapeutic compositions
US3269912A (en) Aluminum oxide depot vaccines
JPH0639386B2 (en) Production method of live adjuvant vaccine
Bailey et al. Modified oesophagoscope for injecting oesophageal varices.
US3720761A (en) Injectable radio-pharmaceutical scanning agent and preparation
KR0162074B1 (en) Solutions containing antigen and zinc hydroxide or iron hydroxide as an adjuvant and processes for preparing such solutions
US2411897A (en) Pharmaceutical solution
US2364579A (en) Hog cholera vaccine
Necheles Effects of glucagon on external secretion of the pancreas
US2518510A (en) Stable injectable oil-pectin therapeutic compositions
US3629425A (en) Stabilized 2-pam solutions
KR100195571B1 (en) Antigen solution treated with zinc hydroxide/calcium hydroxide gel. lecithin and polyalphaolefin and preparation thereof
US3639577A (en) Injectable adjuvant,method of preparing same and compositions including such adjuvant
Rose et al. Studies on the release of histamine from the blood cells of the rabbit by the addition of horse serum or egg albumin in vitro
Rhoads Immunization with mixtures of poliomyelitis virus and aluminum hydroxide
JPS62249928A (en) Medicine for radiation trouble
US4600582A (en) Therapeutic treatment
US2487975A (en) Therapeutic preparations for intramuscular or subcutaneous injection and methods of making the same
US2793156A (en) Repository penicillin products
US2415719A (en) Gelatin vehicle
US3097140A (en) Preparing a mixed polio, pertussis, tetanus, and diphtheria vaccine with benzethonium chloride
Gourzis et al. Alterations in Cardiovascular Responses of the Dog Following Rauwiloid. An Alkaloidal Extract of Rauwolfia serpentina
GB2030043A (en) Injectable composition for the treatment of helminthiasis and clostridial diseases in animals